Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric C Polley

Showing results (71-80 of 113) with videos related to

Pageof 12
Sort By:
JAMA Oncology|April 19, 2017
Associations Between Cancer Predisposition Testing Panel Genes and Breast CancerFergus J Couch, Hermela Shimelis, Chunling Hu, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 10, 2026
Cardiovascular Effects of Alogliptin, Linagliptin, Saxagliptin, and Sitagliptin: A Target Trial Emulation of a Comparative Effectiveness StudyUrja N Kalathiya, Kimberly Yuang, Jeph Herrin, et al.
Journal of the National Cancer Institute|November 4, 2020
Racial and Ethnic Differences in Multigene Hereditary Cancer Panel Test Results for Women With Breast CancerSiddhartha Yadav, Holly LaDuca, Eric C Polley, et al.
Investigational New Drugs|June 18, 2015
Phase I study of the heat shock protein 90 (Hsp90) inhibitor onalespib (AT13387) administered on a daily for 2 consecutive days per week dosing schedule in patients with advanced solid tumorsKhanh Do, Giovanna Speranza, Lun-Ching Chang, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2011
AMP kinase-related kinase NUAK2 affects tumor growth, migration, and clinical outcome of human melanomaTakeshi Namiki, Atsushi Tanemura, Julio C Valencia, et al.
BMJ Open Diabetes Research & Care|February 27, 2026
Comparative safety of sulfonylurea therapies on cardiovascular and severe hypoglycemia outcomes among adults with type 2 diabetes and moderate cardiovascular risk: a target trial emulationStacey Sklepinski, Alexandria A Ratzki-Leewing, Jeph Herrin, et al.
JAMA|June 21, 2018
Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic CancerChunling Hu, Steven N Hart, Eric C Polley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2022
Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional AssayChunling Hu, Lisa R Susswein, Maegan E Roberts, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 14, 2019
A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patientsHolly LaDuca, Eric C Polley, Amal Yussuf, et al.
The Journal of Molecular Diagnostics : JMD|November 26, 2015
Analytical Validation and Application of a Targeted Next-Generation Sequencing Mutation-Detection Assay for Use in Treatment Assignment in the NCI-MPACT TrialChih-Jian Lih, David J Sims, Robin D Harrington, et al.
Pageof 12

Showing results (71-80 of 113) with videos related to

Sort By:
Pageof 12
JAMA Oncology|April 19, 2017
Associations Between Cancer Predisposition Testing Panel Genes and Breast CancerFergus J Couch, Hermela Shimelis, Chunling Hu, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 10, 2026
Cardiovascular Effects of Alogliptin, Linagliptin, Saxagliptin, and Sitagliptin: A Target Trial Emulation of a Comparative Effectiveness StudyUrja N Kalathiya, Kimberly Yuang, Jeph Herrin, et al.
Journal of the National Cancer Institute|November 4, 2020
Racial and Ethnic Differences in Multigene Hereditary Cancer Panel Test Results for Women With Breast CancerSiddhartha Yadav, Holly LaDuca, Eric C Polley, et al.
Investigational New Drugs|June 18, 2015
Phase I study of the heat shock protein 90 (Hsp90) inhibitor onalespib (AT13387) administered on a daily for 2 consecutive days per week dosing schedule in patients with advanced solid tumorsKhanh Do, Giovanna Speranza, Lun-Ching Chang, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2011
AMP kinase-related kinase NUAK2 affects tumor growth, migration, and clinical outcome of human melanomaTakeshi Namiki, Atsushi Tanemura, Julio C Valencia, et al.
BMJ Open Diabetes Research & Care|February 27, 2026
Comparative safety of sulfonylurea therapies on cardiovascular and severe hypoglycemia outcomes among adults with type 2 diabetes and moderate cardiovascular risk: a target trial emulationStacey Sklepinski, Alexandria A Ratzki-Leewing, Jeph Herrin, et al.
JAMA|June 21, 2018
Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic CancerChunling Hu, Steven N Hart, Eric C Polley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2022
Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional AssayChunling Hu, Lisa R Susswein, Maegan E Roberts, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 14, 2019
A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patientsHolly LaDuca, Eric C Polley, Amal Yussuf, et al.
The Journal of Molecular Diagnostics : JMD|November 26, 2015
Analytical Validation and Application of a Targeted Next-Generation Sequencing Mutation-Detection Assay for Use in Treatment Assignment in the NCI-MPACT TrialChih-Jian Lih, David J Sims, Robin D Harrington, et al.
Pageof 12